back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-15 10:20 Tx date 2026-09-11 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,939
+739 vol $9.39 each |
72,704 | |
| Filed 2026-09-09 15:46 Tx date 2026-09-08 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,277
+775 vol $9.39 each |
||
| Filed 2026-09-09 15:47 Tx date 2026-09-08 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
57 - Exercise of rights
|
-1,666 vol |
28,731 | |
| Filed 2026-09-09 15:46 Tx date 2026-09-08 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,277
+775 vol $9.39 each |
72,740 | |
| Filed 2026-06-30 10:24 Tx date 2026-06-29 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,096
+1,763 vol $9.13 each |
71,965 | |
| Filed 2026-06-24 15:30 Tx date 2026-06-24 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$19,353
+2,016 vol $9.60 each |
||
| Filed 2026-06-24 15:31 Tx date 2026-06-24 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
57 - Exercise of rights
|
-4,032 vol |
30,397 | |
| Filed 2026-06-24 15:30 Tx date 2026-06-24 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$19,353
+2,016 vol $9.60 each |
72,218 | |
| Filed 2026-06-15 08:37 Tx date 2026-06-10 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+7,332 vol |
34,429 | |
| Filed 2025-11-24 12:53 Tx date 2025-11-18 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
57 - Exercise of rights
|
-1,666 vol |
27,097 | |
| Filed 2025-11-24 12:53 Tx date 2025-11-24 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,169
+719 vol $8.58 each |
70,202 | |
| Filed 2025-11-12 11:22 Tx date 2025-09-08 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
57 - Exercise of rights
|
-1,667 vol |
28,763 | |
| Filed 2025-11-12 11:20 Tx date 2025-09-08 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,256
+756 vol $5.63 each |
69,483 | |
| Filed 2025-11-12 11:17 Tx date 2024-09-08 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
57 - Exercise of rights
|
-1,667 vol |
13,333 | |
| Filed 2025-11-12 11:16 Tx date 2024-09-08 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,098
+727 vol $11.14 each |
68,727 | |
| Filed 2025-06-25 10:57 Tx date 2025-06-24 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+12,097 vol |
32,097 | |
| Filed 2024-11-28 11:56 Tx date 2024-11-18 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+5,000 vol |
20,000 | |
| Filed 2024-11-28 11:55 Tx date 2023-09-08 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+5,000 vol |
15,000 | |
| Filed 2024-11-28 11:55 Tx date 2022-08-15 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+10,000 vol |
10,000 | |
| Filed 2024-11-28 11:53 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-26 09:44 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,799
+10,000 vol $22.08 each |
33,300 | |
| Filed 2021-05-19 14:58 Tx date 2021-05-19 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$319,793
+18,000 vol $17.77 each |
18,000 | |
| Filed 2021-05-19 14:54 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-20 13:38 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,400
+10,000 vol $17.44 each |
23,300 | |
| Filed 2020-01-09 15:48 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-29,700 vol |
3,300 | |
| Filed 2019-11-20 11:03 Tx date 2019-11-18 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,300
+10,000 vol $11.23 each |
43,000 | |
| Filed 2018-06-18 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,660
+33,000 vol $1.02 each |
33,000 | |
| Filed 2018-06-18 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|